These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 13773597)
1. A monoamine oxidase inhibitor in the treatment of organic disease. MUETHER RO; SCHUETZ A; DEL ROSARIO H; SOMMER AJ J Neuropsychiatr; 1961 Feb; 2(Suppl 1)():80-5. PubMed ID: 13773597 [No Abstract] [Full Text] [Related]
2. Treatment of geriatric patients with etryptamine acetate. KIESSLING AJ J Neuropsychiatr; 1961 Feb; 2(Suppl1)():64-5. PubMed ID: 13755873 [No Abstract] [Full Text] [Related]
4. In vivo metabolism of serotonin and tryptamine: effect of monoamine oxidase inhibition. WEISSBACH H; LOVENBERG W; REDFIELD BG; UDENFRIEND S J Pharmacol Exp Ther; 1961 Jan; 131():26-30. PubMed ID: 13784114 [No Abstract] [Full Text] [Related]
5. The effect of monoamine oxidase inhibitors and tryptophan on the tryptamine content of animal tissues and urine. HESS SM; REDFIELD BG; UDENFRIEND S J Pharmacol Exp Ther; 1959 Nov; 127():178-81. PubMed ID: 14401504 [No Abstract] [Full Text] [Related]
18. Clinical toxicity studies of a monoamine oxidase inhibitor. GREENBLATT IJ; KAHN A Ann N Y Acad Sci; 1959 Sep; 80():947-59. PubMed ID: 13851575 [No Abstract] [Full Text] [Related]